Loading...
XTAEALBA
Market cap93mUSD
Dec 26, Last price  
1,882.00ILS
1D
-0.70%
1Q
24.93%
Jan 2017
-67.00%
Name

Al-Bad Massuot Yitzhak Ltd

Chart & Performance

D1W1MN
XTAE:ALBA chart
P/E
1,161.03
P/S
20.52
EPS
1.62
Div Yield, %
0.00%
Shrs. gr., 5y
7.35%
Rev. gr., 5y
2.60%
Revenues
1.71b
+17.65%
507,497,000584,021,000636,348,000680,772,000689,243,0001,382,850,0001,412,693,0001,445,240,0001,493,762,0001,510,455,0001,454,508,0001,504,701,0001,415,282,0001,578,936,0001,485,911,0001,453,877,0001,710,479,000
Net income
30m
P
23,681,00015,905,00017,449,00023,090,00022,274,00030,897,00015,973,00066,996,00040,227,00054,584,00033,766,000-32,938,000-64,709,000101,310,000-20,340,000-35,123,00030,227,000
CFO
233m
+1,156.08%
4,803,00023,962,00019,525,00039,605,00028,465,000124,489,000112,496,00078,521,00090,716,000118,740,00070,182,00085,181,00097,123,000184,721,00052,579,00018,568,000233,229,000
Dividend
Nov 05, 2020191.11455 ILS/sh

Profile

Albaad Massuot Yitzhak Ltd produces and sells wipes worldwide. It offers cleaning hand wipes including disinfecting and antibacterial wipes; cosmetic wipes, such as facial care, body, and feet care wipes; feminine hygienic product, which include tampons; and baby, maternity, toddler, and household cleaning wipes. The company also provides professional wipes, such as para-medical, veterinary, automotive, and restaurant wipes, as well as sachets; adult wipes including adult bed and bath; personal care wipes, which include intimate wipes; para-pharma wipes and flushable moist toilet paper product. In addition, it offers contract, private label, and institutional manufacturing services. The company was founded in 1985 and is based in Nir Yitzhak, Israel.
IPO date
Jan 01, 1994
Employees
1,994
Domiciled in
IL
Incorporated in
IL

Valuation

Title
ILS in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
1,710,479
17.65%
1,453,877
-2.16%
1,485,911
-5.89%
Cost of revenue
1,543,203
1,390,989
1,373,699
Unusual Expense (Income)
NOPBT
167,276
62,888
112,212
NOPBT Margin
9.78%
4.33%
7.55%
Operating Taxes
13,783
3,457
27,994
Tax Rate
8.24%
5.50%
24.95%
NOPAT
153,493
59,431
84,218
Net income
30,227
-186.06%
(35,123)
72.68%
(20,340)
-120.08%
Dividends
Dividend yield
Proceeds from repurchase of equity
48,279
BB yield
-35.84%
Debt
Debt current
423,675
567,191
239,697
Long-term debt
678,720
493,917
772,213
Deferred revenue
6,066
Other long-term liabilities
60,823
33,975
55,922
Net debt
1,083,262
1,033,922
993,669
Cash flow
Cash from operating activities
233,229
18,568
52,579
CAPEX
(112,246)
(86,147)
(90,663)
Cash from investing activities
(110,941)
(30,364)
(170,240)
Cash from financing activities
(134,492)
20,464
103,676
FCF
88,417
133,421
(86,403)
Balance
Cash
19,133
27,186
18,241
Long term investments
Excess cash
Stockholders' equity
159,844
129,570
261,873
Invested Capital
1,293,095
1,219,299
1,288,218
ROIC
12.22%
4.74%
7.15%
ROCE
12.94%
5.04%
8.47%
EV
Common stock shares outstanding
18,647
18,647
13,081
Price
12.40
71.65%
7.22
-76.92%
31.30
-55.29%
Market cap
231,223
71.65%
134,706
-67.10%
409,450
-55.29%
EV
1,323,648
1,176,464
1,420,058
EBITDA
254,118
156,022
200,461
EV/EBITDA
5.21
7.54
7.08
Interest
34,181
25,549
20,572
Interest/NOPBT
20.43%
40.63%
18.33%